These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 20715908)
1. Safeguarding innovation through an economic downturn. Barker R Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):347-9. PubMed ID: 20715908 [No Abstract] [Full Text] [Related]
2. Into the valley of death: research to innovation. Hudson J; Khazragui HF Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848 [TBL] [Abstract][Full Text] [Related]
3. Outlook: finding improved medicines: the role of academic-industrial collaboration. Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439 [TBL] [Abstract][Full Text] [Related]
7. Africa's leadership in biomedical research: Shifting the center of gravity. Kay S Sci Transl Med; 2015 Nov; 7(314):314ed13. PubMed ID: 26582894 [No Abstract] [Full Text] [Related]
8. Can emerging drug classes improve R&D productivity? Meier C; Cairns-Smith S; Schulze U Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084 [No Abstract] [Full Text] [Related]
9. US doctors earn speaking and consulting fees from drug companies that sponsor their research. McCarthy M BMJ; 2014 Mar; 348():g2410. PubMed ID: 24677695 [No Abstract] [Full Text] [Related]
12. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system]. Pécoul B Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961 [No Abstract] [Full Text] [Related]
13. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness]. Hedner T; Gatenbeck L Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257 [No Abstract] [Full Text] [Related]
14. Lone Star Stroke Consortium: A Collaborative State-Funded Model for Research. Grotta JC; Anderson JA; Brey RL; Kent TA; Hurn PD; Goldberg MP; Savitz SI; Cruz-Flores S; Warach SJ Stroke; 2020 Dec; 51(12):3778-3786. PubMed ID: 33115326 [No Abstract] [Full Text] [Related]
15. APS comments on the 21st century bioeconomy. Physiologist; 2012 Feb; 55(1):23-5. PubMed ID: 22439365 [No Abstract] [Full Text] [Related]
16. Translational research and the evolving landscape for biomedical innovation. Kaitin KI J Investig Med; 2012 Oct; 60(7):995-8. PubMed ID: 22918200 [TBL] [Abstract][Full Text] [Related]
17. Bridging the Academia/Industry Chasm: Proposed Solutions. Beninger P; Boumil M; Salem D; Getz K; Klapholz H; Curfman GD; Jotwani R; Berman H J Clin Pharmacol; 2016 Dec; 56(12):1457-1460. PubMed ID: 27149908 [No Abstract] [Full Text] [Related]
18. Is academic medicine for sale? Angell M N Engl J Med; 2000 May; 342(20):1516-8. PubMed ID: 10816191 [No Abstract] [Full Text] [Related]
19. Crowdsourcing in pharma: a strategic framework. Bentzien J; Bharadwaj R; Thompson DC Drug Discov Today; 2015 Jul; 20(7):874-83. PubMed ID: 25637169 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical industry guide. Strange bedfellows? Moore A Health Serv J; 2002 Nov; 112(5833):suppl 13-5. PubMed ID: 12478712 [No Abstract] [Full Text] [Related] [Next] [New Search]